BroadOak Capital Partners was founded in 2006 by Bill Snider and Lars Hanan with the goal of providing growth capital and advisory services to life sciences companies that are underserved or overlooked by traditional financial services providers.
Today, BroadOak Capital Partners is the industry’s most active life sciences focused, boutique financial institution with offices in Washington, DC and San Francisco that, through its asset management and advisory businesses, invests growth capital in and provides investment banking services to companies operating in the life sciences tools, diagnostics, and biopharma services sectors. BroadOak has invested in more than 50 companies and advised on more than 50 successful M&A transactions.
The scale and dynamics of our industry sector have changed dramatically since BroadOak’s start 15 years ago. Our clients and partners continue to appreciate the consistency of our core focus and approach.
Our team's talent, network, and commitment to client and portfolio companies are unmatched. Get to know BroadOak's team members.